Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04038359
Title A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Subjects With Indolent Non-Hodgkin Lymphoma. (TEMPO)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Verastem, Inc.
Indications

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

follicular lymphoma

CLL/SLL

Therapies

Duvelisib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.